샘플 요청 목록

 카트 문의
시장보고서
상품코드
1784172

세계의 피하 피임 임플란트 시장

Subdermal Contraceptive Implants
발행일: | 리서치사: Global Industry Analysts, Inc. | 페이지 정보: 영문 281 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

피하 피임 임플란트 세계 시장은 2030년까지 16억 달러에 달할 전망

2024년에 11억 달러로 추정되는 피하 피임 임플란트 세계 시장은 2024-2030년 분석 기간 동안 CAGR 6.7%로 성장하여 2030년에는 16억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 에토노게스트렐 임플란트는 CAGR 7.9%를 기록하며 분석 기간 종료까지 11억 달러에 달할 것으로 예상됩니다. 레보노게스트렐 임플란트 부문의 성장률은 분석 기간 동안 CAGR 4.6%로 추정됩니다.

미국 시장은 추정 2억 9,600만 달러, 중국은 CAGR 10.8%로 성장 예측

미국의 피하 피임 임플란트 시장은 2024년에 2억 9,600만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 분석 기간인 2024-2030년 CAGR 10.8%로 2030년까지 3억 3,770만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 3.3%와 6.6%로 예측됩니다. 유럽에서는 독일이 CAGR 4.5%로 성장할 것으로 예측됩니다.

세계의 피하 피임 임플란트 시장 - 주요 동향과 촉진요인 정리

피하 임플란트가 기존 피임약보다 더 많은 지지를 받는 이유는 무엇일까?

피하 피임 임플란트가 전 세계적으로 널리 보급되고 있는 이유는 주로 가임기 여성들 사이에서 장기 지속형 가역적 피임약(LARC)에 대한 선호도가 높아졌기 때문입니다. 매일 복용하는 경구 피임약이나 패치, 주사와 같은 단기 피임법과 달리 피하 임플란트는 한 번의 삽입으로 3-5년 동안 피임이 가능하기 때문에 사용자의 실수 위험을 크게 줄이고 전반적인 효과를 높일 수 있습니다. 시장은 생식권 및 피임 옵션에 대한 인식과 교육이 개선되고 있으며, 특히 의료 접근성이 개선되고 있는 신흥국 시장에서 그 혜택을 누리고 있습니다. 또한, 세계보건기구(WHO), 유엔인구기금(UNFPA), 미국 국제개발처(USAID) 등의 기관들의 공중보건 노력은 출산율이 높고 피임 자원에 대한 접근성이 제한적인 지역에서 임플란트 사용을 적극적으로 장려하고 있습니다. 피하 임플란트는 자궁 내 장치(IUD)에 비해 침습성이 낮고 자궁에 삽입할 필요가 없기 때문에 출산 경험이 없는 여성에게 선호되는 선택지입니다. 임플란트의 최소한의 유지보수, 눈에 잘 띄지 않는 특성, 가역적 기능은 피임에 대한 관점을 바꾸고, 편리성, 자율성, 장기적인 계획으로 이야기를 바꾸고 있습니다. 그 결과, 이러한 피임기구는 도시 지역의 교육 수준이 높은 사람들뿐만 아니라 정부 및 NGO의 지원 프로그램을 통해 농촌 지역과 의료 서비스를 받지 못하는 지역에도 보급되고 있습니다.

의료 정책과 국제 캠페인은 어떻게 보급을 가속화하고 있는가?

정부의 의료 정책과 국제 캠페인은 특히 가족계획에 대한 요구가 충족되지 않는 지역에서 피임 임플란트 채택을 가속화하는 데 핵심적인 역할을 하고 있습니다. 중저소득국가(LMICs)에서는 지속가능개발목표(SDGs)와 같은 프레임워크 하에서 생식보건에 대한 보편적 접근을 위한 움직임이 피임 임플란트의 대규모 조달과 보조금 지급에 박차를 가하고 있습니다. FP2030 파트너십 및 세계 기부자 연합과 같은 이니셔티브는 제조업체와 유리한 가격 협정을 체결하여 전 세계 수백만 명의 여성에게 임플란트가 저렴하거나 무료로 제공되도록 보장합니다. 각국 정부는 특히 사하라 사막 이남 아프리카와 동남아시아에서 피하 임플란트를 공중보건 프로그램에 통합하고, 지역 보건 종사자들에게 교육을 제공하고, 홍보와 신뢰도를 높이기 위해 노력하고 있습니다. 한편, 선진국에서는 여성의 건강, 성평등, 생식 자율성을 둘러싼 정책 전환으로 LARC가 보험 적용을 받아 10대와 젊은 성인들 사이에서 보급이 진행되고 있습니다. 학교와 진료소를 기반으로 한 인식 개선 캠페인은 원격의료 및 약국 기반 모델을 통한 접근성 확대와 함께 더 많은 사람들에게 정보 및 서비스가 제공될 수 있도록 보장합니다. 이러한 정책 및 옹호 활동의 협력적 노력은 낙인을 줄이고, 접근성을 개선하며, 여성들이 생식건강에 대한 정보에 입각한 선택을 할 수 있도록 돕고 있습니다.

기술 혁신으로 인해 기기 디자인 및 수용성이 향상되고 있는가?

임플란트 디자인 및 삽입 방법의 혁신은 의료진과 환자 모두에게 더 매력적이고 안전하며 사용하기 쉬운 임플란트 디자인을 만들어냈습니다. 시장에서는 더 가늘고 유연한 막대를 가지고 삽입과 제거가 쉽고 불편함이 적은 차세대 임플란트로의 전환을 볼 수 있습니다. 생체흡수성 물질과 호르몬 방출 메커니즘의 발전으로 에토노게스트렐과 같은 활성 약물을 보다 일관되고 제어된 형태로 투여할 수 있게 되어 효능이 향상되고 부작용이 감소하고 있습니다. 장비 제조업체들은 또한 시술 시간과 복잡성을 줄여주는 스마트 삽입 키트를 개발하여 의료 서비스 제공자에게 이 방법을 제공하도록 더욱 장려하고 있습니다. 마이크로칩이나 RFID(Radio-Frequency Identification) 태그를 내장하여 투약 정보를 저장하고 환자 추적관리를 용이하게 하는 디지털 또는 추적 가능한 임플란트에 초점을 맞춘 연구도 진행되고 있습니다. 또한, 다양한 사회문화적 배경에서 수용성을 높이기 위해 문화적으로 배려한 패키지와 설명자료가 중요시되고 있습니다. 일부 지역에서는 제거에 대한 우려가 계속되고 있기 때문에 교육 프로그램이 삽입과 안전하고 적시에 제거에 동등하게 초점을 맞추기 위해 노력하고 있습니다. 이러한 모든 기술 발전은 기기를 보다 사용자 중심으로 만들어 환자 만족도를 높이고, 다양한 헬스케어 생태계에 걸쳐 시장 범위를 확장하고 있습니다.

전 세계적으로 임플란트 수요가 증가하는 배경은?

피하 피임 임플란트 시장의 성장은 생식 의료 트렌드, 의료 서비스 접근성, 인구통계학적 변화, 의료 기술 혁신에 기반한 여러 요인에 의해 주도되고 있습니다. 효과적이고 유지보수가 적은 피임에 대한 전 세계적인 수요의 증가는 특히 매일의 순응도 문제 없이 가족계획의 자율성을 원하는 여성들 사이에서 큰 원동력이 되고 있습니다. 도시와 농촌을 막론하고 젊은 층은 눈에 띄지 않는 장기 피임 솔루션에 대한 관심이 높아지고 있으며, 임플란트는 이러한 프로필에 잘 부합합니다. 데이터와 교육 캠페인으로 뒷받침되는 임신 지연 및 간격 유지의 건강 및 경제적 이점에 대한 인식이 높아짐에 따라 더 많은 여성들이 장기 지속형 피임법을 선택하도록 영향을 미치고 있습니다. 또한, 정부 및 NGO가 지원하는 생식 건강 프로그램의 보급으로 인해 더 많은 사회경제적 계층에서 이러한 임플란트 시술이 더 쉽게 이용할 수 있고, 더 저렴한 가격으로 이용할 수 있게 되었습니다. 의료진 입장에서는 임플란트는 투여 프로토콜이 간소화되고, 시술 시간이 단축되며, 다른 방법에 비해 후속 조치가 덜 필요하기 때문에 현재 임플란트 시술이 선호되고 있습니다. 지속시간 연장, 호르몬 투여 개선, 제거 용이성 등 기기 자체의 기술적 개선이 소비자의 신뢰를 높이고 있습니다. 전 세계 규제 기관들도 새로운 모델의 승인과 채택을 서두르고 있으며, 공중 보건적 가치를 인정하고 있습니다. 마지막으로, 가족계획에 대한 문화적 사고방식의 변화와 여성의 교육 및 노동력 참여 증가로 인해 생식 자율성의 중요성이 강화되면서 피하 임플란트는 현대 피임 치료에서 설득력 있는 솔루션이 되고 있습니다.

부문

제품(에토노게스트렐 임플란트, 레보노게스트렐 임플란트), 유통 채널(병원, 부인과 클리닉, 지역 의료 센터, 기타)

조사 대상 기업 사례

  • Allergan plc
  • Baxter International Inc.
  • Bayer AG
  • Bayer Schering Pharma
  • Conceptus Inc.
  • Contraline, Inc.
  • DKT International
  • DKT WomanCare
  • Eli Lilly and Company
  • FHI 360
  • Gerresheimer AG
  • HRA Pharma
  • Karex Industries
  • KESSEL medintim GmbH
  • Leiras Oy
  • Mayer Laboratories
  • Merck & Co., Inc.
  • Novartis AG
  • Organon
  • Pfizer Inc.
  • Population Council
  • Reckitt Benckiser Group plc
  • Sandoz International GmbH
  • Schott AG
  • Shanghai Dahua Pharmaceutical Co., Ltd.
  • SMB Corporation
  • Teva Pharmaceutical Industries Ltd.
  • The Female Health Company
  • Theramex
  • Wyeth Pharmaceuticals

AI 통합

우리는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 일반적인 LLM 및 업계별 SLM 쿼리를 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSM 25.08.13

Global Subdermal Contraceptive Implants Market to Reach US$1.6 Billion by 2030

The global market for Subdermal Contraceptive Implants estimated at US$1.1 Billion in the year 2024, is expected to reach US$1.6 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. Etonogestrel Implant, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$1.1 Billion by the end of the analysis period. Growth in the Levonorgestrel Implant segment is estimated at 4.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$296.0 Million While China is Forecast to Grow at 10.8% CAGR

The Subdermal Contraceptive Implants market in the U.S. is estimated at US$296.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$337.7 Million by the year 2030 trailing a CAGR of 10.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 6.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Global Subdermal Contraceptive Implants Market - Key Trends & Drivers Summarized

Why Are Subdermal Implants Gaining Favor Over Traditional Contraceptives?

Subdermal contraceptive implants are witnessing a notable surge in global adoption, largely due to the growing preference for long-acting reversible contraceptives (LARCs) among women of reproductive age. Unlike daily oral contraceptives or short-term methods like patches and injections, subdermal implants offer protection for three to five years with a single insertion, significantly reducing the risk of user error and increasing overall efficacy. The market is benefitting from increased awareness and education about reproductive rights and contraception options, particularly in developing regions where access to healthcare is improving. Furthermore, public health initiatives by organizations such as the World Health Organization (WHO), UNFPA, and USAID are actively promoting the use of implants in regions with high fertility rates and limited access to contraceptive resources. Compared to intrauterine devices (IUDs), subdermal implants are less invasive and do not require uterine placement, making them a preferred option for women who may not have given birth. The minimal maintenance, discreet nature, and reversible function of implants are reshaping how contraception is viewed, shifting the narrative toward convenience, autonomy, and long-term planning. As a result, these devices are not only finding favor in urban, educated populations but also penetrating rural and underserved areas via government and NGO-supported programs.

How Are Healthcare Policies and Global Campaigns Accelerating Adoption?

Government healthcare policies and international campaigns are playing a central role in accelerating the adoption of subdermal contraceptive implants, especially in regions with unmet needs for family planning. In low- and middle-income countries (LMICs), the push toward universal access to reproductive healthcare under frameworks like the Sustainable Development Goals (SDGs) has spurred large-scale procurement and subsidized distribution of contraceptive implants. Initiatives such as the FP2030 partnership and global donor alliances have secured favorable pricing agreements with manufacturers, ensuring implants are affordable or free to millions of women worldwide. National governments, particularly in Sub-Saharan Africa and Southeast Asia, are integrating subdermal implants into public health programs and providing training for community health workers to increase outreach and trust. Meanwhile, in developed countries, policy shifts around women's health, gender equity, and reproductive autonomy have led to insurance coverage for LARCs, boosting their uptake among teenagers and young adults. School-based and clinic-based awareness campaigns, alongside expanding access via telehealth and pharmacy-based models, are ensuring that information and services reach broader populations. These coordinated policy and advocacy efforts are reducing stigma, improving access, and ensuring that women can make informed choices about their reproductive health-factors that are directly driving growth in the subdermal contraceptive implant market.

Are Technological Innovations Enhancing Device Design and Acceptance?

Yes, technological innovations in implant design and insertion methods are making subdermal contraceptive implants more appealing, safer, and easier to use for both healthcare providers and patients. The market is seeing a shift toward next-generation implants with thinner, more flexible rods that are easier to insert and remove with minimal discomfort. Advancements in bioresorbable materials and hormone release mechanisms are allowing for more consistent and controlled delivery of active agents like etonogestrel, thereby improving efficacy and reducing side effects. Device manufacturers are also developing smart insertion kits that reduce procedural time and complexity, further encouraging healthcare providers to offer the method. Some research efforts are focused on digital or trackable implants, incorporating microchips or radio-frequency identification (RFID) tags that can store dosing information and facilitate patient follow-up. Additionally, there’s an increased emphasis on culturally sensitive packaging and instruction materials, improving acceptance in diverse sociocultural contexts. As removal continues to be a concern in some regions, efforts are being made to ensure training programs focus equally on insertion and safe, timely removal. All these technological strides are making the devices more user-centric, thereby enhancing patient satisfaction and expanding market reach across different healthcare ecosystems.

What’s Behind the Rising Demand for These Implants Around the World?

The growth in the subdermal contraceptive implants market is driven by several factors rooted in reproductive health trends, healthcare access, demographic shifts, and medical innovation. The rising global demand for effective, low-maintenance contraception is a major driver, particularly among women seeking autonomy in family planning without daily adherence challenges. Younger populations in both urban and rural areas are showing increased interest in discreet, long-term contraceptive solutions, and implants fit that profile well. Growing awareness of the health and economic benefits of delayed or spaced pregnancies, supported by data and educational campaigns, is influencing more women to choose long-acting methods. Furthermore, the proliferation of government and NGO-supported reproductive health programs is making these implants more accessible and affordable across a wider range of socioeconomic groups. From a healthcare provider standpoint, implants are now favored due to simplified administration protocols, shorter procedure times, and fewer follow-up requirements compared to alternatives. Technological refinement in the devices themselves-such as longer duration, improved hormone delivery, and easier removability-is reinforcing consumer trust. Regulatory bodies worldwide are also fast-tracking approval and adoption of new models, recognizing their public health value. Lastly, shifting cultural attitudes toward family planning and increased female participation in education and the workforce are reinforcing the importance of reproductive autonomy, making subdermal implants a compelling solution in modern contraceptive care.

SCOPE OF STUDY:

The report analyzes the Subdermal Contraceptive Implants market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Etonogestrel Implant, Levonorgestrel Implant); Distribution Channel (Hospital, Gynecology Clinics, Community Health Care Centers, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

  • Allergan plc
  • Baxter International Inc.
  • Bayer AG
  • Bayer Schering Pharma
  • Conceptus Inc.
  • Contraline, Inc.
  • DKT International
  • DKT WomanCare
  • Eli Lilly and Company
  • FHI 360
  • Gerresheimer AG
  • HRA Pharma
  • Karex Industries
  • KESSEL medintim GmbH
  • Leiras Oy
  • Mayer Laboratories
  • Merck & Co., Inc.
  • Novartis AG
  • Organon
  • Pfizer Inc.
  • Population Council
  • Reckitt Benckiser Group plc
  • Sandoz International GmbH
  • Schott AG
  • Shanghai Dahua Pharmaceutical Co., Ltd.
  • SMB Corporation
  • Teva Pharmaceutical Industries Ltd.
  • The Female Health Company
  • Theramex
  • Wyeth Pharmaceuticals

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Subdermal Contraceptive Implants - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Focus on Long-Acting Reversible Contraceptives (LARCs) Propels Growth in Subdermal Implant Adoption
    • Increased Government and NGO-Led Family Planning Initiatives Expand the Addressable Market in Emerging Economies
    • Shift Toward Female-Centric and Autonomous Contraceptive Methods Strengthens the Business Case for Implants
    • Affordability and High Efficacy of Subdermal Implants Drive Demand in Public Health and Low-Income Settings
    • Growing Acceptance of Minimal-Maintenance Birth Control Solutions Accelerates Demand Across Age Groups
    • Technological Advancements in Implant Materials and Insertion Devices Spur Innovation and Safety Improvements
    • Healthcare Provider Training and Outreach Programs Drive Adoption in Underserved and Rural Populations
    • Changing Social Norms and Awareness Campaigns Generate Demand for Discreet and Long-Term Contraception
    • Rising Insurance Coverage and Reimbursement Support Strengthens Uptake in Developed Markets
    • Expanded Use in Postpartum and Adolescent Contraception Creates New Opportunities for Market Penetration
    • Demand for Reversible and Fertility-Preserving Options Spurs Preference for Implantable Devices
    • Integration of Contraceptive Counseling into Primary Healthcare Systems Supports Long-Term Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Subdermal Contraceptive Implants Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Subdermal Contraceptive Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Subdermal Contraceptive Implants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Etonogestrel Implant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Etonogestrel Implant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Etonogestrel Implant by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Levonorgestrel Implant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Levonorgestrel Implant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Levonorgestrel Implant by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospital by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospital by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Hospital by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Gynecology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Gynecology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Gynecology Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Community Health Care Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Community Health Care Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Community Health Care Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Others by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • JAPAN
    • Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • CHINA
    • Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • EUROPE
    • Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Subdermal Contraceptive Implants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Subdermal Contraceptive Implants by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • FRANCE
    • Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • GERMANY
    • Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Subdermal Contraceptive Implants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Subdermal Contraceptive Implants by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • INDIA
    • Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Subdermal Contraceptive Implants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Subdermal Contraceptive Implants by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Subdermal Contraceptive Implants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Subdermal Contraceptive Implants by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • AFRICA
    • Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제